Willingness to receive a COVID-19 vaccine in people with multiple sclerosis – UK MS Register survey

•94.4% of people with multiple sclerosis (MS) would accept a COVID-19 vaccine•People of increasing age and previous influenza vaccinations were more likely to accept•Safety concerns and lack of information were top reasons for not getting a vaccine•51.7% of people with MS initially surveyed received...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis and related disorders 2021-10, Vol.55, p.103175-103175, Article 103175
Hauptverfasser: Huang, Yun, Rodgers, William J, Middleton, Rodden M, Baheerathan, Aravindhan, Tuite-Dalton, Katherine A, Ford, David V, Nicholas, Richard, Group, MS Register Research
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•94.4% of people with multiple sclerosis (MS) would accept a COVID-19 vaccine•People of increasing age and previous influenza vaccinations were more likely to accept•Safety concerns and lack of information were top reasons for not getting a vaccine•51.7% of people with MS initially surveyed received a COVID-19 vaccine by May 2021•The decision to receive a vaccine changes with evolving perceived risks versus benefits Background & Methods: We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates. Results & Conclusion: 94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in ‘Yes’ group and 27.0% in ‘No’ group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.
ISSN:2211-0348
2211-0356
DOI:10.1016/j.msard.2021.103175